See all treatments in the PatientsLikeMe system shared by patients just like you.
Brand Names:
Rilutek
What is Riluzole?
Riluzole is the first drug to be approved for the treatment of ALS. Riluzole does not cure the disease or improve symptoms, but may extend the survival of patients by approximately three months. Riluzole appears to be more effective in patients with bulbar-onset than for those with limb-onset.
Read more...
See more information, including instructions, precautions, side effects, and interactions.
789 patients in the community are taking or have taken Riluzole.
| Reason | # Patients | Percentage of patients |
|---|---|---|
| Slow my ALS progress | 705 | 92% |
| disease-related symptoms | 17 | 2% |
| Other | 14 | 1% |
| Don't know | 8 | 1% |
| Stiffness/spasticity | 6 | <1% |
| General health | 5 | <1% |
| Fasciculations | 3 | <1% |
| Fatigue | 3 | <1% |
| Bulbar symptoms | 1 | <1% |
| Anxiety | 1 | <1% |
| Pain | 1 | <1% |
How long current patients have been taking Riluzole or how long patients were taking Riluzole before stopping.
Results from 13 patient evaluations. See the overall results and all individual evaluations.
| Moderate | 15% | 2 |
|---|---|---|
| Can't tell | 85% | 11 |
Slow my ALS progress
| Severe | 15% | 2 |
|---|---|---|
| Moderate | 8% | 1 |
| Mild | 0% | 0 |
| None | 77% | 10 |
Top reported side-effects include: Nausea, Fatigue, weakness in lips
Summary results are based on 13 individual responses. For more information, see overall results for Adherence, Burden and Cost.